FIELD: medicine. SUBSTANCE: method involves creating 99 m Tc technefit colloid depot in pleural cavity of pleurisy or pyothorax patient. Blood is taken from patient cubital vein 30 min later and blood pulsations are recorded using scintillation gamma camera or scanner unit. Quantitative evaluation is carried out using a mathematical formula. EFFECT: high accuracy measurements.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING TIMING OF SURGICAL TREATMENT OF TUBERCULOUS PLEURAL EMPYEMA IN CHILDREN | 2021 |
|
RU2756371C1 |
| METHOD OF DETERMINING THE ETNOLOGY OF EXUDATIVE PLEURISY | 0 |
|
SU1173987A1 |
| METHOD FOR STANDARDIZING AND ENCODING FIBROTHORAXES | 2005 |
|
RU2300308C2 |
| METHOD OF DIAGNOSIS TUBERCULOSIS EXUDATIVE PLEURISY | 0 |
|
SU1560089A1 |
| METHOD FOR PREDICTION OF POSTOPERATIVE COMPLICATIONS AND AGGRAVATION OF TUBERCULOSIS PROCESS AFTER SURGICAL INTERVENTION | 2019 |
|
RU2724187C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF PLEURISIES WITH EFFUSIONS | 0 |
|
SU1305602A1 |
| METHOD OF TREATING PLEURAL EMPYEMA | 2017 |
|
RU2661090C1 |
| METHOD OF DETERMINING AETIOLOGY OF EXUDATIVE PLEURITIS | 0 |
|
SU1471127A1 |
| METHOD FOR RESTORING THE DIAPHRAGM WITH AN EXTENSIVE DEFECT AFTER ITS SUBTOTAL REMOVAL DUE TO TUBERCULOUS EMPYEMA OF THE PLEURA | 2022 |
|
RU2784298C1 |
| PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
